Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation

被引:6
|
作者
Ludovini, Vienna [1 ]
Gori, Stefania [1 ]
Pistola, Lorenza [1 ]
Della Fazia, Maria Agnese [2 ]
Piobbico, Danilo [2 ]
Servillo, Giuseppe [2 ]
Flacco, Antonella [1 ]
Seuderi, Cristina [3 ]
Crino, Lucio [1 ]
机构
[1] Osped S Maria Misericordia, Perugia, Italy
[2] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy
[3] Ist Oncol Mediterraneo, Catania, Italy
关键词
D O I
10.1097/JTO.0b013e318169e341
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:452 / 453
页数:2
相关论文
共 11 条
  • [1] Pulmonary Adenoid Cystic Carcinoma with EGFR Activating Mutation and Responds Well with Tyrosine Kinase Inhibitor
    Zaini, J.
    Andarini, S.
    Syahruddin, E.
    Hudoyo, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [2] Long-Lasting Complete Remission in a Patient With Metastatic Metaplastic Breast Cancer Treated With Immune Checkpoint Inhibitor and Chemotherapy: A Case Report and a Review of the Literature
    Al-Awadhi, Aydah
    Alnaqbi, Safia
    Albawardi, Alia
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [3] Complete Remission of Brain Metastases in Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation Treated with Tyrosine Kinase Inhibitor without Radiotherapy: A Report of 3 Cases
    Jung, Yun Hwa
    Han, Chi Wha
    Jung, Yun Duk
    Cho, Young Yun
    Han, Deok Jae
    [J]. CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 149 - 154
  • [4] Long-Lasting Complete Remission of Small-Cell Carcinoma of the Pancreas with Carboplatin and Etoposide Complicated by Gallbladder Adenocarcinoma Diagnosed during Follow-Up
    Tyriakidis, Konstantinos
    Stadlmann, Sylvia
    Pederiva, Stefanie
    [J]. CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 365 - 370
  • [5] Uncommon mutation types of Epidermal Growth Factor Receptor (EGFR) and tyrosine kinase inhibitor response in non-small cell lung carcinoma
    Wong, Maria P.
    Lee, Victor H. F.
    Yeung, Rebecca M. W.
    Tin, Vicky P. C.
    Choy, Kit Chi
    Liu, Jing
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [6] LONG-LASTING COMPLETE REMISSION OF PULMONARY METASTASES CONSEQUENT TO RENAL-CELL CARCINOMA OBTAINED WITH INTERFERON-BETA THERAPY - REVIEW OF THE LITERATURE AND A CASE-REPORT
    SCOPONI, C
    TORRESI, U
    DIGIUSEPPE, M
    [J]. TUMORI, 1995, 81 (03) : 201 - 203
  • [7] Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571):: effect of low dosage in an advanced tumour with exon 11 mutation
    Högenauer, C
    Langner, C
    Lipp, RW
    Höfler, G
    Krejs, GJ
    Hinterleitner, TA
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (03) : 323 - 327
  • [8] Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis
    Xia, Xueming
    Du, Wei
    Zhang, Yan
    Li, Yanying
    Yu, Min
    Liu, Yongmei
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] EGFR-TYROSINE KINASE INHIBITOR TREATMENT BEYOND PROGRESSION IN LONG-TERM RESPONDERS TO ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER: RELEVANCE OF EGFR MUTATION STATUS
    Faehling, M.
    Eckert, R.
    Kamp, T.
    Straeter, J.
    Ott, G.
    Spengler, W.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 440 - 440
  • [10] How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation? A bicenter research and pooled analysis of published reports.
    Liu, Yong-Mei
    Xia, Xueming
    Du, Wei
    Zhang, Yan
    Xu, Jianlin
    Gong, You-Ling
    Xu, Yong
    Zhu, Jiang
    Ding, Zhen-Yu
    Peng, Feng
    Huang, Meijuan
    Wang, Jin
    Ren, Li
    Lu, You
    Han, Baohui
    Wang, Yongsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35